Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bellus Health
Bellus Health
A year after the acquisition of Bellus Health, GSK planning to let go of most former Bellus employees
LinkedIn
Fri, 03/22/24 - 10:50 am
GSK
Bellus Health
M&A
layoffs
After watching Merck's chronic cough drama, GSK knew exactly what not to do with Bellus asset
Fierce Biotech
Thu, 11/30/23 - 10:07 am
Merck
GSK
chronic cough
Bellus Health
gefapixant
Camlipixant
Biopharma’s green shoots thriving in summer sun as deal activity returns
Fierce Biotech
Tue, 07/11/23 - 11:18 pm
M&A
Eli Lilly
Siglion Therapeutics
DiCE Therapeutics
GSK
Bellus Health
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Big Pharmas finally strike with GSK, Merck acquisitions, signaling accelerating pace of M&A
Fierce Pharma
Tue, 04/18/23 - 10:10 pm
Big Pharma
M&A
Merck
Prometheus Biosciences
GSK
Bellus Health
GSK coughs up $2B for Bellus Health
Medical Marketing and Media
Tue, 04/18/23 - 10:24 am
GSK
Bellus Health
M&A
chronic cough
Camlipixant
Biopharma’s stock market winners of 2021 revealed
EP Vantage
Wed, 01/12/22 - 10:50 am
biotech stocks
Eli Lilly
Pfizer
Abbott Labs
Moderna Therapeutics
Merck KGaA
Novo Nordisk
BioNTech
Biohaven
Prothena
Bicycle Therapeutics
Bellus Health
Evolus
Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis
Endpoints
Mon, 12/13/21 - 11:06 am
Bellus Health
chronic cough
Merck
BLU-5937
gefapixant
Bellus says its Merck cough rival passed a PhIIb test after earlier flop, but investors can't make up their minds
Endpoints
Mon, 09/13/21 - 10:40 am
Bellus Health
chronic cough
Merck
clinical trials
Bellus hit with a setback as its PhII chronic cough drug flops on all 4 doses -- shares cremated on Wall Street
Endpoints
Mon, 07/6/20 - 10:24 am
Bellus Health
BLU-5937
clinical trials
chronic cough
Bellus hopes to fuel up on IPO cash as it squares off with giant Merck on a rival drug
Endpoints
Tue, 09/3/19 - 11:30 pm
Bellus Health
IPOs
chronic cough
Merck
CELTIC THERAPEUTICS AND BELLUS HEALTH INITIATE CONFIRMATORY PHASE III CLINICAL STUDY FOR KIACTA
PR-Canada.net
Sat, 12/18/10 - 01:55 pm
Celtic Therapeutics
Bellus Health
Kiacta
AA amyloidosis
rheumatoid arthritis